Midway Pharmaceuticals

About:

Midway Pharmaceuticals is a developer of specialty drugs designed to provide beneficial effects in the treatment of gastrointestinal.

Website: http://www.midwaypharma.com/

Top Investors: BioAdvance

Description:

Midway Pharmaceuticals is a developer of specialty drugs designed to provide beneficial effects in the treatment of gastrointestinal and systemic diseases. The company's specialty drugs focus on finding high molecular weight polymers that can be consumed orally and inhibit the pathogenic behavior of bacteria in the GI tract, enhance gut barrier function and promote gastrointestinal healing, enabling healthcare institutions to avail enhanced drugs to protect people's guts from radiation damage and infection.

Total Funding Amount:

$500000

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Spring House, Pennsylvania, United States

Founded Date:

2005-01-01

Contact Email:

Info(AT)midwaypharma.com

Founders:

Elaine Petrof, Eugene Chang, John Alverdy, Rifat Pamukcu

Number of Employees:

1-10

Last Funding Date:

2008-11-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai